Teal Valley T.TV

Primary Symbol: P.TEAL

Healthcare Cannabis

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.

P.TEAL - Post by User

Teal Valley

Bullboard Posts

Post by LongTbuffeton Jun 25, 2019 4:41am

143 Views

Post# 29859006

The first Quarter results says it all. Undervalued.

First Quarter Highlights:
(Compared to first quarter 2018, unless otherwise noted)

Excellent safety performance – reduction of lost-time injuries, with only one recorded, down from eleven.
Solid quarterly zinc production of 100.6 million payable pounds – annual production on track to achieve 2019 guidance.
Strong on-site cost control – Operating costs per tonne1 lowered by 4%. Third-party factors led to higher C1 Cash Costs1 and AISC1 costs, including higher zinc concentrate treatment charges and costs associated with selling additional concentrate.
Improved Adjusted EBITDA1 of $52.0 million – concentrate inventory reductions led to strong sales volumes and resulted a 6% increase in adjusted EBITDA1.
Strengthened leadership team – appointment of Jessica McDonald as Chair of the Board of Directors and Ricus Grimbeek as President and Chief Executive Officer.
Debt levels lowered – $40.0 million in principal repaid and $168.6 million available and undrawn on revolving credit facility, further strengthening an already robust balance sheet.